Syndax Pharmaceuticals (SNDX) Revenue (2016 - 2020)
Historic Revenue for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to $380000.0.
- Syndax Pharmaceuticals' Revenue changed 0.0% to $380000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $380000.0, marking a year-over-year decrease of 7495.06%. This contributed to the annual value of $23.7 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2020, Syndax Pharmaceuticals' Revenue is $380000.0, which was down 0.0% from $379000.0 recorded in Q3 2020.
- Syndax Pharmaceuticals' 5-year Revenue high stood at $1.2 million for Q4 2017, and its period low was $305000.0 during Q1 2016.
- Moreover, its 5-year median value for Revenue was $379000.0 (2018), whereas its average is $393950.0.
- Per our database at Business Quant, Syndax Pharmaceuticals' Revenue skyrocketed by 169411.76% in 2016 and then plummeted by 6814.75% in 2018.
- Quarter analysis of 5 years shows Syndax Pharmaceuticals' Revenue stood at $305000.0 in 2016, then surged by 291.15% to $1.2 million in 2017, then crashed by 68.15% to $380000.0 in 2018, then changed by 0.0% to $380000.0 in 2019, then changed by 0.0% to $380000.0 in 2020.
- Its last three reported values are $380000.0 in Q4 2020, $379000.0 for Q3 2020, and $379000.0 during Q2 2020.